Atlanta, Georgia, September
3, 2009
U.S. News & World Report recently issued its annual list of
America’s best hospitals and 94 percent of the top cancer
hospitals in the country are users of Elekta solutions. For
patients throughout the U.S., this means the vast majority of
the best cancer treatment facilities also have the best
information management, treatment planning and delivery systems
available.
"This distinction is a tribute to the enthusiastic leadership
and dedicated teamwork of each and every hospital nominated,”
states Jay Hoey, President and CEO of Elekta North America.
“Every day, they demonstrate their commitment to put patients
first, and Elekta is honored to be a part of that."
U.S. News & World Report grades hospitals not on routine
procedures but on how well they manage complex, demanding
situations. The 1,859 hospitals that met the initial selection
criteria received a score between 0 and 100. This score was
based on the hospitals’ reputation, death rate, patient safety
and care-related factors such as nursing and patient services.
The 50 highest-scoring hospitals were ranked.
These hospitals were ranked in 16 specialties such as cancer,
orthopedics, urology and heart disease. Only 174 hospitals – of
the 4,861 in the original analysis – scored high enough to be
ranked in even one of the 16 specialties. Of these hospitals, an
Honor Roll of 21 Best Hospitals was chosen.
Of the 21 top hospitals listed, all provide care with the help
of a solution from Elekta. In the top 50 cancer specialty
hospitals listed, 47 utilize Elekta equipment or software,
including:
-
Monaco®, an advanced, clinically relevant IMRT planning system
that brings innovative concepts to the clinic. Monaco helps make
the planning process easier, more straightforward and clinically
reliable.
- MOSAIQ®
2.0, a comprehensive oncology information solution that
simplifies the management of patients from the moment they enter
the cancer center through long-term follow-up. MOSAIQ 2.0
increases process efficiency, allows clinicians real-time access
to clinical information and facilitates the highest quality
patient care.
- Leksell
Gamma Knife® or Leksell Gamma Knife® Perfexion™, a non-invasive
method for treating brain tumors and other neurological
disorders. Finely adapted to intracranial radiosurgery, Leksell
Gamma Knife systems are preferred for their accuracy, efficiency
and outstanding therapeutic response. 25 of the top 50 hospitals
listed (50%) are Leksell Gamma Knife® users.
- Elekta
Axesse™, a leading-edge stereotactic treatment system that's
perfectly suited for stereotactic radiosurgery procedures
anywhere in the body.
- Elekta
Infinity, the only fully integrated treatment system that allows
personalization of imaging and treatment workflows. Infinity can
dramatically reduce IMRT treatment times with the flexibility of
multiple arcs to improve conformance.
U.S.
News & World Report has issued the annual rankings of medical
centers for the last 20 years. The full rankings can be viewed
at
usnews.com/besthospitals.
About Elekta
Elekta
is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The
company develops sophisticated, state-of-the-art tools and
treatment planning systems for radiation therapy and
radiosurgery, as well as workflow enhancing software systems
across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer
confidence to both healthcare providers and patients, Elekta
aims to improve, prolong and even save patient lives, making the
future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in
more than 5,000 hospitals globally, and every day more than
100,000 patients receive diagnosis, treatment or follow-up with
the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate
headquarter is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. For more
information about Elekta, please visit
www.elekta.com. |
